NDC00023-0773-50: GRISEOFULVIN TABLETS,ULTRAMICROS.
GRISEOFULVIN TABLETS,ULTRAMICROS. Key specifications include administration: ORAL, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 500.000 TABLETS, active_medicament_medicinal_strength: 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT, american_hospital_formulary_service_classification_number: 081204. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-254-9596, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 500.000 TABLETS |
| active_medicament_medicinal_strength | 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT |
| american_hospital_formulary_service_classification_number | 081204 |
| NSN | 6505-01-254-9596 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 081204 |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 250.000 MILLIGRAMS GRISEOFULVIN ACTIVE INGREDIENT |